Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Shetland ponies help allergy sufferers
Shetland
“To our knowledge, this is the very first study of a natural allergic disease in which we can show that immune responses to allergens can take two directions."

Horse immune system acts in two different ways in response to midge bites

Shetland ponies are helping researchers understand how people could be prevented from developing allergies, according to a new study.

Researchers at the University of Edinburgh said that the horse immune system responds to midge bites in a way that prevents, rather than triggers, allergic reactions.

The study of Shetland ponies found that their immune system acts in two different ways in response to midge bites.

One of these responses triggers allergy symptoms, such as itching and inflammation, while the other prevents an allergic reaction.

The team found that after being exposed to midges, the horse immune system releases various types of factors, known as cytokines, which affect the behaviour of other cells.

Ponies that react to midge bites release cytokines, known as IL-4, which trigger allergy symptoms.

In ponies not sensitive to bites, another cytokine, INF-g, is released, blocking different immune cells that would otherwise trigger allergic reactions.

The researchers say that by priming the human immune system to respond to allergens in a way that does not trigger reactions, it could be possible to prevent people developing allergies.

Lead author of the study, Dr Dietmar Zais from the University of Edinburgh's School of Biological Sciences, said:  “To our knowledge, this is the very first study of a natural allergic disease in which we can show that immune responses to allergens can take two directions, either leading to allergy or to tolerance.

"We believe this finding could have direct practical implications, for example by helping immune responses to choose the 'right' direction in individuals who we would like to protect from developing occupation-associated allergies.”

The study, published in the journal PLOS ONE, was funded by the Dutch Foundation for Technical Sciences (STW) and was carried out in collaboration with researchers in the Netherlands.

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com